Stuart Iain
Insider CIK 1727756 · MNLO Chief Scientific Officer · FOMX SVP R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-07-23 | 2026-07-24 | 15,405 | $0.90 | $13.9K | 95,944 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-06-30 | 2026-07-02 | 2,370 | $0.65 | $1.5K | 111,349 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-03-31 | 2026-04-02 | 2,876 | $0.60 | $1.7K | 112,363 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-12-31 | 2026-01-05 | 2,448 | $0.58 | $1.4K | 115,239 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-09-30 | 2025-10-02 | 2,453 | $0.34 | $834 | 117,687 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-06-30 | 2025-07-02 | 2,453 | $1.65 | $4.0K | 120,140 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-03-31 | 2025-04-02 | 6,044 | $1.58 | $9.5K | 122,593 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2025-01-21 | 2025-01-23 | 230,000 | — | $0 | 230,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-12-31 | 2025-01-02 | 4,857 | $3.35 | $16.3K | 128,637 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-09-30 | 2024-10-02 | 109 | $1.88 | $205 | 133,494 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-07-01 | 2024-07-03 | 138 | $1.92 | $265 | 133,603 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-04-01 | 2024-04-03 | 157 | $3.08 | $484 | 133,741 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-01-02 | 2024-01-03 | 157 | $2.28 | $358 | 133,898 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2024-01-01 | 2024-01-03 | 62,500 | — | $0 | 62,500 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2024-01-01 | 2024-01-03 | 62,500 | — | $0 | 134,055 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2023-12-13 | 2023-12-15 | 62,500 | — | $0 | 62,500 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2023-12-13 | 2023-12-15 | 62,500 | — | $0 | 71,555 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-10-02 | 2023-10-04 | 1,184 | $3.83 | $4.5K | 9,055 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-06-30 | 2023-07-05 | 151 | $4.10 | $619 | 10,239 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-03-31 | 2023-04-04 | 480 | $3.08 | $1.5K | 10,390 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-12-31 | 2023-01-04 | 1,720 | $0.15 | $258 | 220,252 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-09-30 | 2022-10-04 | 1,719 | $0.22 | $378 | 221,972 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-06-30 | 2022-07-05 | 1,719 | $0.39 | $670 | 223,691 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-03-31 | 2022-04-04 | 3,469 | $0.65 | $2.3K | 225,410 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2022-03-17 | 2022-03-18 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2022-03-17 | 2022-03-18 | 75,000 | — | $0 | 228,879 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-12-31 | 2022-01-04 | 1,250 | $1.02 | $1.3K | 153,879 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-09-30 | 2021-10-01 | 1,480 | $1.39 | $2.1K | 155,129 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2021-09-02 | 2021-09-03 | 60,860 | — | $0 | 60,860 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2021-09-02 | 2021-09-03 | 60,859 | — | $0 | 156,609 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-06-30 | 2021-07-02 | 3,083 | $3.51 | $10.8K | 95,750 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-03-31 | 2021-04-02 | 1,945 | $6.84 | $13.3K | 98,833 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2021-02-22 | 2021-02-24 | 68,162 | — | $0 | 68,162 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2021-02-22 | 2021-02-24 | 29,213 | — | $0 | 100,778 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2020-12-31 | 2021-01-05 | 2,378 | $1.58 | $3.8K | 286,262 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2020-09-30 | 2020-10-02 | 2,378 | $1.66 | $3.9K | 288,640 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-06-30 | 2020-07-02 | 2,378 | $1.73 | $4.1K | 291,018 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-05-06 | 2020-05-08 | 112,500 | — | $0 | 112,500 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-05-06 | 2020-05-08 | 112,500 | — | $0 | 293,401 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-04-06 | 2020-04-07 | 3,763 | $1.40 | $5.3K | 180,901 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 27,530 | — | $0 | 86,982 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 97,682 | — | $0 | 184,664 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-03-31 | 2020-04-02 | 1,940 | $2.68 | $5.2K | 59,452 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 96,365 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 40,000 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 13,000 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 30,000 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 75,997 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 17,772 | — | $0 | 17,772 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 45,020 | — | $0 | 45,020 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 57,086 | — | $0 | 57,086 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 7,701 | — | $0 | 7,701 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 23,696 | — | $0 | 23,696 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 91,303 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 12,333 | — | $0 | 91,303 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 7,306 | — | $0 | 7,306 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 54,086 | — | $0 | 61,392 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2020-02-24 | 2020-02-24 | 96,365 | — | $0 | 96,365 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2020-02-24 | 2020-02-24 | 41,299 | — | $0 | 103,636 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | F Tax w/h | 2019-12-31 | 2020-01-03 | 514 | $3.28 | $1.7K | 62,337 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | F Tax w/h | 2019-09-30 | 2019-10-02 | 673 | $3.07 | $2.1K | 62,851 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2019-07-01 | 2019-07-03 | 951 | $2.35 | $2.2K | 63,524 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2019-04-01 | 2019-04-03 | 1,696 | $3.75 | $6.4K | 64,475 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2019-01-01 | 2019-01-03 | 75,997 | $3.77 | $286.5K | 75,997 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2019-01-01 | 2019-01-03 | 32,569 | — | $0 | 66,171 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-11-08 | 2018-11-13 | 683 | $4.58 | $3.1K | 33,602 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-08-08 | 2018-08-09 | 2,715 | $5.68 | $15.4K | 34,285 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2018-02-27 | 2018-02-28 | 30,000 | $6.35 | $190.5K | 30,000 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2018-02-27 | 2018-02-28 | 10,000 | — | $0 | 37,000 | SEC↗ |